Established in 2011, the academic spinoff GenProbio offers Next Generation Sequencing (NGS) Core Facility to provide cutting edge next generation sequencing technology to its users. Next Generation Sequencing has become a key analysis method for biological research. The capacity to expand analysis from more or less defined genomic regions to genome wide studies has improved the pace of research discovery and enabled researchers to obtain a global view on biological processes. Advice and management of sequencing projects are offered by our team that relies on years of experience with sequencing systems and sequencing data analysis.

GenProbio uses state-of-art-technologies to understand how to improve the scientific basis and understanding of the functionality of probiotic bacteria by means of genomics approaches.

GenProbio is dedicated to deliver its customers high quality services that support novel probiotic products with solid scientific validation.